热门资讯> 正文
Inmagene BiopharmPharmaceuticals的Ikena Oncology任命Kristin Yarema为首席执行官
2025-07-23 21:43
- Ikena Oncology (NASDAQ:IKNA) and Inmagene Biopharmaceuticals on Wednesday announced the appointment of Kristin Yarema, Ph.D. as chief executive officer of ImageneBio, of the combined company after the anticipated closing.
- Kristin Yarema brings over two decades of leadership experience in human therapeutics to Imagene, the company said. Yarema joins the team after most recently serving as President and CEO and as a member of the Board of Directors of Poseida Therapeutics.
- IKNA is +5.65% to $1.31.
- Source: Press Release
More on Ikena Oncology
- Seeking Alpha’s Quant Rating on Ikena Oncology
- Financial information for Ikena Oncology
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
